Search Orphan Drug Designations and Approvals
-
Generic Name: | Istiratumab |
---|---|
Date Designated: | 10/22/2014 |
Orphan Designation: | Treatment of pancreatic cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Merrimack Pharmaceuticals, Inc. One Kendall Square Suite B7201 Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-